Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online June 22, 2007
Diabetes Care 30:2355-2361, 2007
DOI: 10.2337/dc07-0440
© 2007 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dc07-0440v1
30/9/2355    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by André, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by André, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Cardiovascular and Metabolic Risk
Original Article

{gamma}-Glutamyltransferase Activity and Development of the Metabolic Syndrome (International Diabetes Federation Definition) in Middle-Aged Men and Women

Data From the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort

Philippe André, MD1,2, Beverley Balkau, PHD1,2, Sylviane Vol, MSC3, Marie Aline Charles, MD1,2, Eveline Eschwège, MD1,2 on behalf of the DESIR Study Group*

1 Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 780-IFR69, Epidemiological and Biostatistical Research, Villejuif, France
2 Université Paris-Sud, Villejuif, France
3 Institut Inter Régional pour la Santé, La Riche, France

Address correspondence and reprint requests to Philippe André, MD, INSERM U780-IFR69, 16 Avenue Paul Vaillant-Couturier, F-94807, Villejuif Cedex, France. E-mail: andre{at}vjf.inserm.fr

OBJECTIVE—Among hepatic enzymes, {gamma}-glutamyltransferase (GGT) is the main predictor of type 2 diabetes incidence, although it has not been shown that GGT predicts pre-diabetes states. Our aim was to study the association of GGT with the development of the metabolic syndrome (MetS).

RESEARCH DESIGN AND METHODS—We analyzed the 3-year data from the Data from Epidemiological Study on the Insulin Resistance Syndrome prospective cohort of 1,656 men and 1,889 women without MetS at baseline, according to the International Diabetes Federation definition.

RESULTS—Over 3 years, 309 participants developed the MetS. After adjustment for age, alcohol intake, physical activity, smoking habits, and alanine aminotransferase (ALT), the odds ratios for incident MetS increased across baseline GGT quartiles (1, 1.96, 2.25, and 3.81 in men, P < 0.03; and 1, 1.23, 1.80, and 1.58 in women, P < 0.05). After additional adjustment for insulin resistance markers (fasting insulin or homeostasis model assessment of insulin resistance index), the association was attenuated and the linear relation no longer significant in both sexes (P = 0.08, P = 0.16). However, men in the highest in comparison to the lowest quartile of GGT retained a significant risk for incident MetS. In women, there was no longer a significant risk. GGT was significantly associated with the 3-year incidence of individual components of the MetS. The incidence of the MetS also increased with ALT, but after adjustment on GGT this association remained significant only in women.

CONCLUSIONS—GGT, a predictor of type 2 diabetes, was associated with a risk of incident MetS. This association was mainly related with insulin resistance but was independent of other confounding factors.

Abbreviations: ALT, alanine aminotransferase • AST, aspartate aminotransferase • DESIR, Data From Epidemiological Study on the Insulin Resistance Syndrome • FPG, fasting plasma glucose • GGT, {gamma}-glutamyltransferase • IDF, International Diabetes Federation • IFG, impaired fasting glucose • HOMA-IR, homeostasis model assessment of insulin resistance • MetS, metabolic syndrome


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.